Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

Grant Success: Dr. Andrea Georgiou, our Marie Curie Fellow, secures first independent research €150,000 grant

No Comments
| News

We are excited to announce that Dr. Andrea Georgiou, our esteemed Marie-Curie Fellow at the Zanos Lab, has secured her first grant as Principal Investigator! The Research and Innovation Foundation in Cyprus has awarded Dr. Georgiou a prestigious €150,000 grant to advance her innovative research program. Dr. Georgiou’s funded project focuses on unraveling the molecular […]

Read More »

Exciting news for the Zanos Lab: €100,000 funds awarded for laboratory equipment and consumables!

No Comments
| News

We are thrilled to announce that the Translational Neuropharmacology Lab (Zanos Lab) has been awarded €100,000 in state funds to support our cutting-edge research. These funds will be used to upgrade our laboratory equipment and ensure a steady supply of essential consumables, enabling us to advance our mission of understanding and developing novel therapies for […]

Read More »

Dr. Onisiforou from the Zanos lab presents novel findings at IDWeek 2024 in Los Angeles, USA

No Comments
| News

We are excited to announce that Dr. Onisiforou from our lab is currently participating in IDWeek 2024, taking place in Los Angeles, USA. IDWeek is a premier international conference bringing together researchers and clinicians to discuss the latest advancements in infectious diseases. At the conference, Dr. Onisiforou is presenting her novel research on the molecular […]

Read More »

Dr. Zanos and Dr. Onisiforou at the Science of Alzheimer’s & Infectious Diseases symposium in California, USA

No Comments
| News

We are pleased to share that Dr. Zanos and Dr. Onisiforou from our lab recently participated in the Science of Alzheimer’s & Infectious Diseases Symposium, hosted by the IDSA Foundation. The symposium focused on the emerging connections between infectious diseases and Alzheimer’s disease (AD), bringing together leading experts to discuss the latest scientific advancements in […]

Read More »

Congratulations to Dr. Polymnia Louka for securing a Marie-Curie co-fund grant to work in the Zanos lab

No Comments
| News

We are excited to announce that Dr. Polymnia Louka, our new postdoctoral researcher, has successfully secured €150,000 in funding through the European Marie-Curie Co-Fund. The grant will support her research project titled “Identifying the Effects of Ketamine and Its Metabolites on Depression-Induced Impairment in Bone Health.” Dr. Louka’s project aims to address a critical gap […]

Read More »

New computational publication: A novel algorithm to uncover comorbid disease mechanisms

No Comments
| News

We are excited to announce the publication of our latest research in the Computational & Structural Biotechnology Journal, titled “One Path, Two Solutions: Network-Based Analysis Identifies Targetable Pathways for the Treatment of Comorbid Type II Diabetes and Neuropsychiatric Disorders.” This study introduces a novel computational algorithm that provides unprecedented insight into the shared molecular mechanisms […]

Read More »

The Zanos Lab was awarded €200,000 grant to study Hydroxynorketamine’s antidepressant cellular and molecular mechanisms

No Comments
| News

We are thrilled to announce that the Zanos Lab has been awarded a grant to investigate the cellular and molecular mechanisms behind the antidepressant actions of (2R,6R)-hydroxynorketamine ((2R,6R)-HNK), in collaboration with Prof. Kobi Rosenblum. This metabolite of ketamine has shown promise in inducing rapid antidepressant effects without the adverse effects associated with ketamine itself in […]

Read More »

Dr. Zanos was invited and presented new findings on ketamine’s mechanism of antidepressant action at the 11th mGlu 2024 conference in Sicily

No Comments
| News

We are excited to announce that Dr. Zanos recently presented at the prestigious mGlu 2024 meeting in Sicily, Italy. His talk, titled “Interplay between the mGluR2 signalling and ketamine’s rapid antidepressant actions: Exploring the possible role of NMDAR activation,” offered key insights into the mechanisms underlying ketamine’s antidepressant effects. Stay tuned for more research updates […]

Read More »

Zanos Lab at the European Research Night 2024 in Cyprus

No Comments
| News

We are excited to share that Zanos Lab participated in this year’s European Research Night (ERN) event in Cyprus, an initiative aimed at bringing research and innovation closer to the public. During the event, we had the opportunity to engage with students and visitors, offering insights into our ongoing research projects focused on addiction. Our […]

Read More »

Our postdoctoral fellow, Dr. Andria Michael, was awarded a Marie Skłodowska-Curie Young Investigator grant (€147.000) for Innovative research in the Zanos lab

No Comments
| News

We are thrilled to announce that our postdoctoral fellow, Dr. Andria Michael, from the Zanos lab, has been awarded a prestigious Marie Skłodowska-Curie young investigator grant under the ONISILOS co-fund scheme. This grant will support Dr. Michael’s innovative research aimed at identifying the role of Vascular Endothelial Growth Factor A (VEGF-A) in the development of […]

Read More »

Posts pagination

Previous 1 … 7 8 9 … 13 Next

Recent Posts

  • New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? March 12, 2026
  • New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis February 24, 2026
  • New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms January 29, 2026
  • Dr. Zanos Appointed to the Editorial Board of the Neuropharmacology Journal January 17, 2026
  • Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine January 4, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress